Clinical Trial Update: Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of asenapine, with comparisons to placebo and olanzapine, in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)
• olanzapine (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED